Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
Neuropharmacology December 1, 2015 Anna Rickli, Dino Luethi, Julian Reinisch et al. 216 citations
N-2-methoxybenzyl-phenethylamines (NBOMe drugs) are newly used psychoactive substances with poorly defined pharmacological properties. The aim of the present study was to characterize the receptor binding profiles of a series of NBOMe drugs compared with their 2,5-dimethoxy-phenethylamine analogs (2C drugs) and lysergic acid diethylamide (LSD) in vitro. We investigated the binding affinities of...
DOI: 10.1016/j.neuropharm.2015.08.034 (opens in new tab)
Full text (opens in new tab)
Affinity
Hallucinogens
Novel psychoactive substances
Phenethylamines
+1